At 12 wk VISA-A score improved to 18.9 units ( 7.4 ) in the treatment group , revealing a blood-injection effect of 9.6 units ( 11.5 ) , relative to a comparatively unchanged condition in control ( 9.4 units ; 9.0 ) .
